Pharmaceutical system in Ukraine: current and prospective issues
Journal Title: JOURNAL OF HEALTH POLICY & OUTCOMES RESEARCH - Year 2015, Vol 8, Issue 2
Abstract
ntroduction: To review the current pharmaceutical system in the private and public sectors in Ukraine in terms of the availability and affordability of medicines, to explore and analyze national health system reforms started to be introduced in 2015. Methods: The captured data was analyzed using the predetermined themes of financing, pricing, reimbursement, reforms and market analysis in Ukraine. We also examined the prices and volumes of medicines in 2013-2015. Results: This analysis showed the dynamics of key indicators of the pharmaceutical market of Ukraine for 2013-2015. We used data from the MOH, market research analytical system “PharmXplorer”, “Pharmstandard” company “Proxima Research”. Conclusions: The analysis of retail sales of drugs on the pharmaceutical market of Ukraine for the last 3 years indicates a decreasing sales trend in number of packages and dollar values. The current structure of market is characterized by the inadequate consumption of drugs, a high use of medicines for symptomatic treatment, increasing the average drug cost, medical devices, generic drugs dominance and lack of legislative regulation of pricing for the original drugs. Importantly, positive results of reimbursement of medicines for hypertension indicated an urgent need to introduce mechanisms for reimbursement of other medicines for the treatment of diabetes and some socially important diseases. In Ukraine the capacity building and educational programs on HTA for pharmacists have already started. That is necessary to implement the requirements to health technology assessment to prioritize the procurements of medicines and their financing by government according to the developed scientific methodology.
Authors and Affiliations
Olha Zaliska, Oresta Pinyazhko, Natalia Maksymovych, Orest Sichkoriz, Viacheslav Tolubaiev
Keywords
Related Articles
- EP ID EP192174
- DOI 10.7365/JHPOR.2015.2.8
- Views 86
- Downloads 0
The combination of angiotensin converting enzyme inhibitors, diuretics and non-steroidal anti-inflammatory drugs in the routine community pharmacy settings in Poland: The unrecognized problem of ‘Triple Whammy’. A pilot analysis.
Background: ‘Triple Whammy’ defined as a combination of angiotensin converting enzyme inhibitors/angiotensin receptor antagonist, diuretics and non-steroidal anti-inflammatory drugs remains an important clinical problem,...
Assessment of thrombocytopenia symptoms using vignettes. Preliminary report on the development and implementation of a new instrument
Objective: Our aim was to create a vignette enabling the assessment of the impact of thrombocytopenia symptoms on patients’ quality of life. Methods: The vignettes which we created are focused on thrombocytopenia sym...
The study of the need for interprofessional collaboration in the health care system in Poland - experience of Lesław A. Paga Foundation.
Background: Interprofessional collaboration (IC) in healthcare is a process by which professionals from different disciplines collaborate to provide an integrated and cohesive approach to patient care. The Lesław A. Paga...
Aging society: organization of long-term care for the elderly in Poland.
Background: Aging society is one of the main challenges of the organization and provision of health care in XXI century. In 2030 more than one third of Polish population will be older than 65 years old and every tenth...
Assessment of quality of life, disease activity and productivity loss of patients with ulcerative colitis in Poland
Purpose: The aim of the study was to assess the relationship between the disease activity and both indirect costs and health-related quality of life among ulcerative colitis (UC) patients in Poland. Methods: A questionn...